[논문]Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

Lau, G.K.K.; Liang, R.; Wu, P.C.; Lee, C.K.; Lim, W.L.; Au, W.Y.

doi:10.1016/S0168-8278(98)80307-3

[해외논문] Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.28 no.3, 1998년, pp.359 - 368

Lau, G.K.K. (Department of Medicine Queen Mary Hospital,, , Hong Kong) , Liang, R. , Wu, P.C. , Lee, C.K. , Lim, W.L. , Au, W.Y.

Abstract ▼ AI-Helper

Background/Aims: Reactivation of chronic hepatitis B viral infection causes significant morbidity and mortality after bone marrow transplantation. Recently, nucleoside analogues, such as famciclovir, were found to have a direct suppressive effect on hepatitis B virus replication in both in vitro and in vivo studies. We have studied the effect of famciclovir on the incidence of hepatitis B virus reactivation and hepatitis after allogeneic bone marrow transplantation.Methods: Eight hepatitis B surface antigen (HBsAg)-positive patients who received allogeneic bone marrow transplantation were given oral famciclovir 250 mg three times daily, starting at least 1 week prior to bone marrow transplantation and continuing for 24 weeks after transplantation. Clinical and serological outcomes in these patients were compared with 24 HBsAg-positive recipients of allogeneic bone marrow transplantation who did not receive famciclovir (historical controls)Results: After bone marrow transplantation, there were five patients with hepatitis B virus reactivation among those who received famciclovir 250 mg three times daily. Four of these patients responded to increased dosages of 500 mg three times daily and did not develop hepatitis. The remaining patient suffered from hepatitis B virus reactivation. Compared to historical controls, there were fewer cases of hepatitis due to hepatitis B virus reactivation and veno-occlusive disease. The median follow-up was 701.6 days (range: 50-2346 days) with ten deaths (three due to hepatic failure related to HBV reactivation) in those who did not receive famciclovir and one death (due to hepatic failure related to graft-versus-host disease) in those who received famciclovir.Conclusions: Use of the famciclovir significantly reduced hepatitis due to hepatitis B virus reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.

참고문헌 (39)

Ann Intern Med Hoffnagle 96 447 1982 10.7326/0003-4819-96-4-447 Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

상세보기
Lancet Galbraith ii 528 1975 10.1016/S0140-6736(75)90897-1 Fulminant hepatic failure in leukemia and choriocacinoma related to withdrawal of cytotoxic drug therapy

상세보기
Q J Med Bird 73 895 1989 Acute liver decomposition on withdrawal of cytotoxic therapy and immunosuppressive therapy in hepatitis B carriers
Q J Med Lau 36 47 1989 Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients
Gastroenterology Scullard 81 978 1981 10.1016/S0016-5085(81)80002-9 Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B

상세보기
Gastroenterology Davis 92 2028 1987 10.1016/0016-5085(87)90641-X Reactivation of chronic hepatitis B virus infection

상세보기
Hematol Oncol Liang 8 261 1990 10.1002/hon.2900080504 Hepatitis B infection in patients with lymphomas

상세보기
Gastroenterology Lok 100 182 1991 10.1016/0016-5085(91)90599-G Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy

상세보기
Bone Marrow Transplant Lau 19 795 1997 10.1038/sj.bmt.1700744 Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case-controlled study

상세보기
Dig Dis Sci Pariente 33 1185 1988 10.1007/BF01535798 Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

상세보기
N Engl J Med Dientstag 333 1657 1995 10.1056/NEJM199512213332501 A preliminary trial of lamuvidine for chronic hepatitis B infection

상세보기
J Viral Hepatitis Main 3 211 1996 10.1111/j.1365-2893.1996.tb00098.x A double blind, placebo-controlled study to assess the effect of famciclovir on viral replication in patients with chronic hepatitis B virus infection

상세보기
J Hepatol Schalm 22 52 1995 New nucleosides analogues for chronic hepatitis B
Hepatology Kruger 22 219A 1995 10.1016/0270-9139(95)94599-7 Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation

상세보기
Hepatology Rabinovitz 24 282A 1996 Famciclovir for recurrent hepatitis B (HBV) infection after liver transplantation
Antimicrob Agents Chemother Shaw 38 719 1994 10.1128/AAC.38.4.719 In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

상세보기
Transplantation Jones 44 778 1987 10.1097/00007890-198712000-00011 Venoocclusive disease of the liver following bone marrow transplantation

상세보기
Transplantation Glucksberg 18 295 1974 10.1097/00007890-197410000-00001 Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

상세보기
J Clin Oncol Beyer 13 1328 1995 10.1200/JCO.1995.13.6.1328 Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

상세보기
Hepatology Lau 25 1497 1997 10.1002/hep.510250631 Clearance of HBsAg after bone marrow transplantation: role of adoptive immunity transfer

상세보기
Nucleic Acids Res Symp Ser Urdea 24 197 1991 Branched DNA amplification multimer for the sensitive, direct detection of human hepatitis viruses
J Hepatol Chung 17 208 1993 10.1016/S0168-8278(05)80040-6 Re-evaluation of α-interferon treatment of chronic hepatitis B using polymerase chain reaction

상세보기
Hepatology Lau 23 1318 1996 Hepatic expression of hepatitis C virus in chronic hepatitis C: a study by in-situ reverse transcription polymerase chain reaction
Lancet Jarvis 348 1352 1996 10.1016/S0140-6736(96)04041-X Infection with hepatitis G virus among recipients of plasma products

상세보기
Hepatology Knodell 1 431 1981 10.1002/hep.1840010511 Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

상세보기
Am J Clin Pathol Wu 105 87 1996 10.1093/ajcp/105.1.87 Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection

상세보기
Proc Natl Acad Sci USA Nowak 93 4398 1996 10.1073/pnas.93.9.4398 Viral dynamics in hepatitis B virus infection

상세보기
J Hepatol Roche 26 517 1997 10.1016/S0168-8278(97)80416-3 De novo and apparent de novo hepatitis B virus infection after liver transplantation

상세보기
Proc Natl Acad Sci USA Tur Kaspa 83 1627 1986 10.1073/pnas.83.6.1627 Hepatitis B virus DNA contains a glucocorticoid-responsive element

상세보기
J Hepatol Aye 26 1148 1997 10.1016/S0168-8278(97)80125-0 Hepatitis B virus polymerase mutation during famciclovir therapy in patients with following liver transplantation

상세보기
Hepatology Trepo 24 188A 1996 Efficacy of famciclovir in chronic hepatitis B: results of a dose finding study
J Hepatol Trepo 26 74 1997 Long-term efficacy of famciclovir (FVC) in chronic hepatitis B: results of a phase IIB study
Ann Intern Med Lok 116 957 1992 10.7326/0003-4819-116-11-957_2 Recovery from hepatitis B [letter]

상세보기
Gastroenterology Ilan 104 1818 1993 10.1016/0016-5085(93)90664-X Ablation of persistent hepatitis B by BMT from a hepatitis B immune donor

상세보기
Blood Lum 69 369 1987 10.1182/blood.V69.2.369.369 The kinetics of immune reconstitution after human marrow transplantation

상세보기
Gastroenterology Hoofnagle 95 1318 1988 10.1016/0016-5085(88)90367-8 Randomised, controlled trial of recombinant human-interferon in patients with chronic hepatitis B

상세보기
Lancet Lok ii 298 1988 10.1016/S0140-6736(88)92355-0 Long-term follow-up in a randomised controlled trial of recombinant-interferon in Chinese patients with chronic hepatitis B virus infection

상세보기
Lancet Alexander ii 66 1987 10.1016/S0140-6736(87)92735-8 Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

상세보기
J Clin Oncol Ayash 8 1699 1990 10.1200/JCO.1990.8.10.1699 Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphoma

상세보기

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

원문 URL 링크

DOI : 10.1016/S0168-8278(98)80307-3
European Association for the Study of the Liver : 저널
Elsevier : 저널

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

저작권 관리 안내

내보내기 메뉴

내보내기 구분

파일저장
인쇄
메일전송

구성항목

기본정보
상세정보

관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관

저장형식

Text(ASCII format)
Excel format
RefWorks Direct Export
RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley

메일정보

받는사람 (필수): @
보내는사람 (선택): @
제목
내용: KISTI 검색결과 이메일 서비스

안내

총 건의 자료가 검색되었습니다.

다운받으실 자료의 인덱스를 입력하세요. (1-10,000)

검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다.

데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요)

다운로드 파일은 UTF-8 형태로 저장됩니다.
파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오.

Text(ASCII format)
Excel format

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

연합인증